default author photo

Jean-Louis Boulay

University of Basel - Brain Tumor Biology and Immunotherapy Group

Klingelbergstrasse 50-70

Basel, CH-4056

Switzerland

  • University of Basel - Brain Tumor Biology and Immunotherapy Group

SCHOLARLY PAPERS

4

DOWNLOADS

190

TOTAL CITATIONS

0

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Quantitative Proteomic Analysis Reveals Different Functional Subtypes Among IDH-Wildtype Glioblastoma

Number of pages: 45 Posted: 27 Jun 2024
Jean-Louis Boulay, Michèle Amer Salem, Marie-Françoise Ritz, Florian S. Halbeisen, Alexander Schmidt, Katarzyna Buczak, Gregor Hutter and Severina Leu
University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Surgical Outcome Research Center Basel, University of Basel - Proteomics Core Facility, University of Basel - Proteomics Core Facility, University of Basel - Brain Tumor Biology and Immunotherapy Group and University of Basel - Brain Tumor Biology and Immunotherapy Group
Downloads 97 (704,534)

Abstract:

Loading...

Proteomics, Glioma, Glioblastoma, Biomarkers, Pathway, Prognosis

2.

Quantitative Proteomics Reveals Global Reduction of Endocytic Machinery Components in Gliomas

Downloads 32 (725,554)

Quantitative Proteomics Reveals Global Reduction of Endocytic Machinery Components in Gliomas

Number of pages: 33 Posted: 15 Mar 2019
Dominik Buser, Marie-Françoise Ritz, Suzette Moes, Cristobal Tostado, Stephan Frank, Martin Spiess, Luigi Mariani, Paul Jenö, Jean-Louis Boulay and Gregor Hutter
University of Basel - Biozentrum, University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Proteomics Core Facility, University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Division of Neuropathology, University of Basel - Biozentrum, University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Proteomics Core Facility, University of Basel - Brain Tumor Biology and Immunotherapy Group and University of Basel - Brain Tumor Immunotherapy Group
Downloads 32 (1,326,242)

Abstract:

Loading...

3.

Proteomic Analysis of Glioma Reveals Distinct Patterns of Pathways  Among High-Grade Glioma Subgroups

Number of pages: 62 Posted: 23 May 2023
Jean-Louis Boulay, Michèle Amer Salem, Marie-Françoise Ritz, Florian S. Halbeisen, Alexander Schmidt, Katarzyna Buczak, Gregor Hutter and Severina Leu
University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Surgical Outcome Research Center Basel, University of Basel - Proteomics Core Facility, University of Basel - Proteomics Core Facility, University of Basel - Brain Tumor Biology and Immunotherapy Group and University of Basel - Brain Tumor Biology and Immunotherapy Group
Downloads 32 (1,290,922)

Abstract:

Loading...

Proteomics, Glioma, Prognosis, Pathway, Biomarkers, Targeted therapy

4.

Quantitative Proteomic Analysis Reveals Different Functional Subtypes Among Idh-Wildtype Glioblastoma

Number of pages: 28 Posted: 14 Aug 2024
Jean-Louis Boulay, Michèle Amer Salem, Marie-Françoise Ritz, Florian S. Halbeisen, Alexander Schmidt, Katarzyna Buczak, Gregor Hutter and Severina Leu
University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Brain Tumor Biology and Immunotherapy Group, University of Basel - Surgical Outcome Research Center Basel, University of Basel - Proteomics Core Facility, University of Basel - Proteomics Core Facility, University of Basel - Brain Tumor Biology and Immunotherapy Group and University of Basel - Brain Tumor Biology and Immunotherapy Group
Downloads 29 (1,332,057)

Abstract:

Loading...

Proteomics, glioma, glioblastoma, Biomarkers, Pathway